Variant report
Variant | nsv879577 |
---|---|
Chromosome Location | chr4:92373327-92429961 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:92034306..92035417-chr4:92423226..92424074,5 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1922230 | chr4:92373327-92373328 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs541460112 | chr4:92373354-92373355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536977257 | chr4:92373391-92373392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564482902 | chr4:92373395-92373396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556895785 | chr4:92373409-92373410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576753913 | chr4:92373444-92373445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182581889 | chr4:92373450-92373451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565433546 | chr4:92373472-92373473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188200277 | chr4:92373475-92373476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6834057 | chr4:92373499-92373500 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs564519243 | chr4:92373527-92373528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370598644 | chr4:92373530-92373531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114041539 | chr4:92373531-92373532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548911780 | chr4:92373561-92373562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562431606 | chr4:92373593-92373594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6834106 | chr4:92373618-92373619 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs540961618 | chr4:92373655-92373656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367768156 | chr4:92373659-92373660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372084391 | chr4:92373669-92373670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571390769 | chr4:92373701-92373702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1955376 | chr4:92373722-92373723 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs547851646 | chr4:92373725-92373726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529515055 | chr4:92373767-92373768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547946134 | chr4:92373784-92373785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563408539 | chr4:92373799-92373800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576814140 | chr4:92373823-92373824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539292057 | chr4:92373825-92373826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558902944 | chr4:92373904-92373905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151197190 | chr4:92373910-92373911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368838790 | chr4:92373944-92373945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139147299 | chr4:92373999-92374000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1997499 | chr4:92374029-92374030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149809975 | chr4:92374032-92374033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551743738 | chr4:92374045-92374046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145754599 | chr4:92374054-92374055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374948603 | chr4:92374203-92374204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372369146 | chr4:92374280-92374281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185247449 | chr4:92374283-92374284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564965945 | chr4:92374287-92374288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74972502 | chr4:92374292-92374293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377219467 | chr4:92374298-92374299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377134103 | chr4:92374313-92374314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs58012222 | chr4:92374343-92374344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35952203 | chr4:92374372-92374373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189835010 | chr4:92374373-92374374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550222459 | chr4:92374392-92374393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113340384 | chr4:92374455-92374456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192531712 | chr4:92374498-92374499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184808746 | chr4:92374504-92374505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188355044 | chr4:92374596-92374597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92370600-92375200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr4:92371400-92375000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:92372000-92375000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr4:92373800-92374200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr4:92375000-92375400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr4:92375000-92375400 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr4:92375000-92375400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr4:92375000-92375800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr4:92375200-92375600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr4:92408000-92408800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:92408200-92408600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr4:92408200-92408600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr4:92408200-92408800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr4:92408400-92408600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr4:92408400-92408800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr4:92408600-92409600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
17 | chr4:92408600-92409600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
18 | chr4:92408800-92410000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
19 | chr4:92408800-92410000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
20 | chr4:92409600-92410000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr4:92409800-92410000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
22 | chr4:92410000-92410400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
23 | chr4:92410200-92410400 | Enhancers | HUES64 Cell Line | embryonic stem cell |